India-based Spinchrom Life Sciences to Market Innovative BLItzTM Platform from Pall’s ForteBio Division

  India-based Spinchrom Life Sciences to Market Innovative BLItzTM Platform
  from Pall’s ForteBio Division

Business Wire

PORT WASHINGTON, N.Y. -- April 17, 2013

Pall Corporation (NYSE: PLL), a global leader in filtration, separation and
purification, today announced that Pall India Pvt. Ltd. has entered into an
exclusive India distribution agreement with a leading biosupplier, Spinchrom
Life Sciences, a division of Spinco Biotech Pvt. Ltd. Through the agreement,
Spinchrom will become the exclusive distributor to market in India ForteBio’s
BLItz system, a revolutionary platform that uniquely enables scientists to
conduct label-free analyses of proteins using small sample volumes easily and
cost-efficiently at their laboratory bench. ForteBio is a division of Pall
Life Sciences and a leading supplier of label-free technology that accelerates
the development of biotherapeutic and pharmaceutical products.

The BLItz (TM) system takes up less surface area than a tablet personal
computer. (Photo: Business W ...

The BLItz (TM) system takes up less surface area than a tablet personal
computer. (Photo: Business Wire)

Historically, institutions have used label-free assays selectively and
relegated them to their core laboratories due to their high complexity and
expense. This practice creates bottlenecks in biotherapeutic research and
development, as scientists may wait days or weeks to schedule their
experiments and then hours or longer to obtain results. The BLItz system is
small — taking up less surface area than a tablet personal computer — so it
can fit easily in an individual scientist’s workspace. It is simple to use and
requires only four microliters of sample — 15 to 20 times less volume than
needed for traditional, surface plasmon resonance (SPR)-based label-free
assays or microplate-based ELISA assays. The BLItz system is designed for any
researcher working with proteins, particularly those who analyze column
fractions, monitor protein expression, perform reagent QC, identify mechanism
of action and signaling and run protein engineering studies. Additionally, the
BLItz system’s Dip and Read™ assays utilize disposable, ready-to-use
biosensors that uniquely provide results in seconds to minutes.

“Given the growing biosimilar and proteomic activity in India, scientists’
ability to understand protein interactions is increasingly a key success
factor. The BLItz technology offers great value by means of a very
cost-effective, simple and fast technology platform,” says Mr. Sachin Indane,
Director – BioPharm, Pall India Pvt. Ltd. “The BLItz platform will
revolutionize the use of label-free protein analysis here by making it more
accessible than ever to individual bench scientists and this will help to
further advance biotherapeutic development in India.”

The BLItz system utilizes the same Bio-Layer Interferometry (BLI) technology
that powers ForteBio’s flagship Octet^® instrumentation platform, which
enables real-time kinetics, affinity and quantitation measurements in
high-throughput applications, with unprecedented ease of use and

“We are excited about teaming with Pall. This partnership enables us to
position the innovative BLItz label-free protein analysis technology as a
complementary tool to our existing Proteomics portfolio thereby offering
customers comprehensive solutions for protein characterization and interaction
studies,” says Mr. C. Ravindranath, Managing Director, Spinco Group of

More information about the BLItz system can be found at

About Pall Corporation

Pall Corporation (NYSE: PLL) is a filtration, separation and purification
leader providing solutions to meet the critical fluid management needs of
customers across the broad spectrum of life sciences and industry. Pall works
with customers to advance health, safety and environmentally responsible
technologies. The company’s engineered products enable process and product
innovation and minimize emissions and waste. Pall Corporation is an S&P 500
company serving customers worldwide. Pall has been named a “top green company”
by Newsweek magazine. To see how Pall is helping enable a greener, safer, more
sustainable future, follow us on Twitter @PallCorporation or visit

About ForteBio, Inc.

ForteBio is a division of Pall Life Sciences. ForteBio provides analytical
systems to accelerate biotherapeutic drug discovery and development. These
systems enable real-time, label-free analysis of biomolecular interactions,
providing information on affinity, kinetics and concentration. ForteBio’s
analytical capabilities enable significantly easier, faster and better
characterization of drug candidates, thus providing greater value in drug
development applications where existing methods have limitations in
throughput, performance and cost. For more information, visit

About Spinchrom Life Sciences

Spinchrom ( is the Life Science equipment & consumables
business unit of Spinco group, ranked as the #1 Biosupplier in India. With a
network of 33 Offices and 450+ Spincoites across the country, Spinchrom helps
accelerate science with innovative workflow solutions.

Photos/Multimedia Gallery Available:



Doug Novarro
Pall Corporation
Corporate Public Relations
Follow us on Twitter @pallcorporation
Press spacebar to pause and continue. Press esc to stop.